Scientists at IIT Kanpur have uncovered how the experimental vaccine booster EP67 enhances immune responses by selectively activating key immune cells while limiting inflammation. Published in PNAS, the discovery could lead to safer, longer-lasting vaccines with fewer side effects and improved protection against infectious diseases, pending successful human clinical trials.